Compare, Analyse Biocon with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ACTAVIS
EQUITY SHARE DATA
    BIOCON
Mar-21
ACTAVIS
Dec-18
BIOCON /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs48814,255-   
Low Rs2759,562-   
Sales per share (Unadj.) Rs59.23,496.8-  
Earnings per share (Unadj.) Rs7.7-1,126.3-  
Cash flow per share (Unadj.) Rs13.7368.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs62.314,422.6-  
Shares outstanding (eoy) m1,200.00332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.43.4 189.0%   
Avg P/E ratio x49.4-10.6 -467.4%  
P/CF ratio (eoy) x27.932.3 86.3%  
Price / Book Value ratio x6.10.8 741.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m457,3503,960,852 11.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m17,4100-   
Avg. sales/employee Rs ThNM68,818.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,166.4-  
INCOME DATA
Net Sales Rs m71,0581,163,028 6.1%  
Other income Rs m6,05222,241 27.2%   
Total revenues Rs m77,1101,185,269 6.5%   
Gross profit Rs m13,14530,477 43.1%  
Depreciation Rs m7,151497,169 1.4%   
Interest Rs m57767,113 0.9%   
Profit before tax Rs m11,469-511,564 -2.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,470 0.0%   
Tax Rs m2,215-6,483 -34.2%   
Profit after tax Rs m9,254-374,612 -2.5%  
Gross profit margin %18.52.6 705.9%  
Effective tax rate %19.31.3 1,524.0%   
Net profit margin %13.0-32.2 -40.4%  
BALANCE SHEET DATA
Current assets Rs m76,004477,013 15.9%   
Current liabilities Rs m42,101421,982 10.0%   
Net working cap to sales %47.74.7 1,008.3%  
Current ratio x1.81.1 159.7%  
Inventory Days Days13720 697.4%  
Debtors Days Days6366 94.3%  
Net fixed assets Rs m106,142131,648 80.6%   
Share capital Rs m6,0000-   
"Free" reserves Rs m68,7280-   
Net worth Rs m74,7284,796,948 1.6%   
Long term debt Rs m29,6161,689,179 1.8%   
Total assets Rs m182,1467,498,722 2.4%  
Interest coverage x20.9-6.6 -315.2%   
Debt to equity ratio x0.40.4 112.5%  
Sales to assets ratio x0.40.2 251.5%   
Return on assets %5.4-4.1 -131.6%  
Return on equity %12.4-7.8 -158.6%  
Return on capital %11.5-4.8 -238.5%  
Exports to sales %00-   
Imports to sales %7.20-   
Net fx Rs m6,7070-   
CASH FLOW
From Operations Rs m11,597415,506 2.8%  
From Investments Rs m-36,247228,266 -15.9%  
From Financial Activity Rs m25,640-713,133 -3.6%  
Net Cashflow Rs m723-69,014 -1.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.67 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: TTK HEALTHCARE  WANBURY  LINCOLN PHAR  SMS LIFESCIENCES INDIA  ADVANCED ENZYME TECHNOLOGIES  



Today's Market

Sensex Opens Flat; Tata Motors & NTPC Top Gainers(09:30 am)

Asian stock markets opened lower today as investors tried to digest the crisis at Chinese property giant Evergrande. Markets in Korea and Hong Kong were shut.

Related Views On News

BIOCON 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of BIOCON for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BIOCON . Also includes updates on the valuation of BIOCON .

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Sep 22, 2021 10:14 AM

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

Top Small Caps to Buy Now

How to Use P/E Ratio in Investing.

India's Edge in Electric Vehicle Stocks

Ditch Warren Buffett and Follow this Gentleman

More Featured Videos

MARKET STATS